Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CMV Disease”

521 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 521 results

Early research (Phase 1)Study completedNCT01986010
What this trial is testing

Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)

Who this might be right for
Cytomegalovirus Infections
Merck Sharp & Dohme LLC 190
Large-scale testing (Phase 3)Study completedNCT03699254
What this trial is testing

Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients.

Who this might be right for
Transplantation InfectionCytomegalovirus Infections
Maimónides Biomedical Research Institute of Córdoba 150
Testing effectiveness (Phase 2)Study completedNCT04225923
What this trial is testing

Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Who this might be right for
Cytomegalovirus Disease
Nobelpharma 87
Early research (Phase 1)Study completedNCT01535885
What this trial is testing

Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

Who this might be right for
Epstein-Barr Virus InfectionsAdenovirusCytomegalovirus Infections
Medical College of Wisconsin 25
Post-approval studies (Phase 4)Study completedNCT02328963
What this trial is testing

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

Who this might be right for
Transplantation InfectionCytomegalovirus Infection
University Hospital, Bordeaux 186
Not applicableStudy completedNCT02715752
What this trial is testing

A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin

Who this might be right for
Herpes Simplex InfectionsHuman PapillomavirusEpstein-Barr Virus Infections+2 more
The Center for the Biology of Chronic Disease 1,000
Testing effectiveness (Phase 2)Study completedNCT05041426
What this trial is testing

Letermovir for CMV Prevention After Lung Transplantation

Who this might be right for
Lung TransplantCMV
Fernanda P Silveira, MD, MS 15
Not applicableStudy completedNCT00005547
What this trial is testing

Infection and Cardiovascular Disease

Who this might be right for
Cardiovascular DiseasesCoronary DiseaseCerebrovascular Accident+7 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT05898048
What this trial is testing

CMV Reactivation in Acute Necrotizing Pancreatitis

Who this might be right for
Acute Necrotizing Pancreatitis
Sanjay Gandhi Postgraduate Institute of Medical Sciences 41
Not applicableStudy completedNCT06568055
What this trial is testing

Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United Kingdom

Who this might be right for
Cytomegalovirus (CMV)
Takeda 330
Not applicableUnknownNCT03973359
What this trial is testing

Epidemiology and Prevention of Congenital HCMV in Immune Mothers. Congenital HCMV Infection Lombardy

Who this might be right for
Congenital Cytomegalovirus InfectionMaternal Cytomegalovirus Infection
Fondazione IRCCS Policlinico San Matteo di Pavia 23,500
Post-approval studies (Phase 4)WithdrawnNCT04183738
What this trial is testing

Inflammation and Co-Infections in D²EFT

Who this might be right for
HIV-infection/AidsHuman Herpesvirus 4 InfectionsCytomegalovirus Infections+2 more
Kirby Institute
Testing effectiveness (Phase 2)WithdrawnNCT02346617
What this trial is testing

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

Who this might be right for
Cytomegalovirus Infections
Yae-Jean Kim
Not applicableActive Not RecruitingNCT04916704
What this trial is testing

Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis

Who this might be right for
ANCA Associated Vasculitis
University Hospital Birmingham NHS Foundation Trust 70
Not applicableLooking for participantsNCT06494033
What this trial is testing

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

Who this might be right for
Lung Diseases
University of Miami 100
Testing effectiveness (Phase 2)UnknownNCT05969743
What this trial is testing

Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease

Who this might be right for
Graft-versus-host-diseaseCMV
Rabin Medical Center 42
Large-scale testing (Phase 3)Ended earlyNCT00201448
What this trial is testing

Evaluation of the Safety and Immune Responses of the Towne Strain of CMV in Seronegative Women

Who this might be right for
Cytomegalovirus Infections
Virginia Commonwealth University 82
Not applicableUnknownNCT03806764
What this trial is testing

Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient

Who this might be right for
Cytomegalovirus InfectionsHaematological MalignancyOrgan or Tissue Transplant; Complications+1 more
Melbourne Health 370
Testing effectiveness (Phase 2)Study completedNCT00000836
What this trial is testing

A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT)

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Study completedNCT00711035
What this trial is testing

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)

Who this might be right for
Adenovirus InfectionEBV Infection
Baylor College of Medicine 50
Load More Results